NCT06043011 - Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms | Biotech Hunter

Enrollment

2,950

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions

Chronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Waldenström's Macroglobulinemia (WM)

Interventions

OTHER

Routine care as per site standard.

Physician's choice according to patient's needs.

Trial Locations (1)

Unknown

RECRUITING

Praxis für Interdisziplinäre Hämatologie und Onkologie, Freiburg im Breisgau

All Listed Sponsors

lead

iOMEDICO AG

INDUSTRY